LCR83 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to CD83 Antibody

CD83 is a cell surface molecule belonging to the immunoglobulin superfamily, primarily expressed on mature dendritic cells but also found on activated B cells and subsets of T cells. The CD83 antibody is used to target these cells, particularly in the context of immune modulation and therapeutic applications.

Function and Mechanism of CD83 Antibody

CD83 antibodies can modulate immune responses by targeting mature dendritic cells, which are crucial for antigen presentation and T cell activation. By depleting these cells, CD83 antibodies can suppress T cell responses, making them potential therapeutic agents for autoimmune diseases and transplant rejection.

Mechanism Highlights:

  • Depletion of Mature Dendritic Cells: CD83 antibodies can induce antibody-dependent cellular cytotoxicity (ADCC), leading to the depletion of mature dendritic cells.

  • Immune Suppression: This depletion results in reduced T cell activation and proliferation, which can be beneficial in autoimmune conditions.

  • Selective Action: CD83 antibodies tend to spare resting B cells and immature dendritic cells, preserving some immune functions.

Research Findings

Recent studies have demonstrated the efficacy of CD83 antibodies in various models:

Study Highlights:

  • Autoimmune Diseases: In models of rheumatoid arthritis, CD83 antibodies have shown promise by reducing disease severity through immune suppression .

  • Transplantation: These antibodies may help prevent graft-versus-host disease by inhibiting alloreactive T cell responses .

Data and Tables

ApplicationEffect of CD83 AntibodyKey Findings
Autoimmune DiseasesImmune SuppressionReduces severity of arthritis by targeting mature dendritic cells .
TransplantationPrevention of Graft-Versus-Host DiseaseInhibits alloreactive T cell responses, preserving anti-viral and anti-tumor T cell responses .
B Cell ResponsesInhibition of B Cell ActivationSelectively depletes activated B cells, reducing antibody production .

References:

  1. CD83 Antibody Inhibits Human B Cell Responses to Antigen as well as Dendritic Cell-Mediated CD4 T Cell Responses. Journal of Immunology, 2018;200(10):3460–3469. doi: 10.4049/jimmunol.1701595 .

  2. Anti-Mouse CD83 Monoclonal Antibody Targeting Mature Dendritic Cells Provides Protection Against Collagen Induced Arthritis. Frontiers in Immunology, 2022;13:784528. doi: 10.3389/fimmu.2022.784528 .

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate-Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
LCR83 antibody; At5g54225 antibody; MDK4Putative defensin-like protein 70 antibody; Putative low-molecular-weight cysteine-rich protein 83 antibody; Protein LCR83 antibody
Target Names
LCR83
Uniprot No.

Target Background

Database Links
Protein Families
DEFL family
Subcellular Location
Secreted.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.